Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy.

Smoking has a strong causal association with bladder cancer but the relationship with recurrence is not well established. We sought to assess the association of smoking status on recurrence of non-muscle invasive bladder cancer (NMIBC) in a contemporary cohort of patients with predominantly high-risk, recurrent NMIBC managed with photodynamic enhanced cystoscopy.

We performed a retrospective study of patients with NMIBC included in a multi-institutional registry. Our primary exposure of interest was smoking status. Our primary outcome was first recurrence of NMIBC. Kaplan-Meier analysis was used to calculate recurrence free probabilities and Cox proportional hazards regression was used to evaluate the impact of smoking status on recurrence free survival.

Our analytic cohort included 723 adults with bladder cancer, 11.5% with primary NMIBC and 88.5% with recurrent NMIBC. The majority of patients were white, male, and had high-risk NMIBC (72.6%). 52.6% of included patients were former smokers and 12.7% were current smokers. During the three-year study period, there was a NMIBC recurrence in 259 of the 723 patients (35.8%). The 1- and 3-year probability of recurrence was 19% and 44%, respectively. The grade and stage of recurrences were 28.9% LG Ta, 34.4% HG Ta, 15.8% pure CIS, 0.3% LG T1, 15.4% HG T1, and 5.4% unknown. After adjustment for a priori clinical and demographic factors, smoking status had no significant association with recurrence.

Smoking status was not significantly association with recurrence in a study of patients with predominantly high-risk recurrent NMIBC managed with photodynamic enhanced cystoscopy.

Urologic oncology. 2021 May 27 [Epub ahead of print]

Richard S Matulewicz, Kourosh Ravvaz, John A Weissert, Sima Porten, Gary D Steinberg, Blue Light Cystoscopy with Cysview Registry Group

Department of Population Health, New York University Grossman School of Medicine, New York, NY; Department of Urology, New York University Grossman School of Medicine, New York, NY. Electronic address: ., Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI., Department of Urology, University of California, San Francisco, CA., Department of Urology, New York University Grossman School of Medicine, New York, NY.

email news signup